Targeting of the VEGF-kinase inhibitor PTK787 to angiogenic vasculature using RGD-equipped albumin carrier molecules.

K. Temming, M. Lacombe, H. E. Moorlag, S. A. Asgeirsdottir, L. Orfi, G. Kéri, K. Poelstra, G. Molema, R. J. Kok

Research output: Contribution to journalArticle

1 Citation (Scopus)
Original languageEnglish
Pages (from-to)e57
JournalJournal of controlled release : official journal of the Controlled Release Society
Volume116
Issue number2
DOIs
Publication statusPublished - Nov 28 2006

ASJC Scopus subject areas

  • Pharmaceutical Science

Cite this